Salubris Pharmaceuticals
Blood & Organ Banks · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6009 Shennan Rd, Futian District, Shenzh...Phone Number
+86 75583767888Website
www.salubris.comRevenue
$6.8 MillionIndustry
ZI Rank: 4
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
1
2
2
4
4
About Salubris Pharmaceuticals
Salubris (Suzhou) Pharmaceuticals Co., Ltd. is a wholly-owned subsidiary as well as an important business unit for biologics development of Shenzhen Salubris Pharmaceuticals Co., Ltd. The company consists of business operation units that focus on process development and optimization, prokaryotic production by E. coli fermentation and eukaryotic production by mammal cell cultivation, and final drug product production of multiple presentations (cartridges, prefilled syringes, penicillin vials). The eukaryotic production lines have the state of art production technology, 2000L Flexfactory production platform, which can be used for clinical production and commercial production of extracellular expression products such as CHO cells.Explore more
Salubris Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Salubris Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Salubris Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Salubris Pharmaceuticals launches new products
Check out if Salubris Pharmaceuticals is spiking on competitors!
Check if Salubris Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Salubris Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Salubris Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Salubris Pharmaceuticals
Salubris Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Salubris Pharmaceuticals is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Salubris Pharmaceuticals is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Salubris Pharmaceuticals.
Salubris Pharmaceuticals Tech Stack
A closer look at the technologies used by Salubris Pharmaceuticals
Salubris Pharmaceuticals News & Media
Viracta Therapeutics Reacquires Exclusive Development and Commercialization Rights for its All-Oral Combination Therapy in China
SAN DIEGO, Aug. 23, 2021 /PRNewswire/ -- Viracta Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that it has reacquired the exclusive rights to develop and commercialize its all-oral combination product candidate in...Viracta and Salubris Announce Equity Financing and Partnership to Bring Novel Treatment for Viral-Associated Cancers to China
SAN DIEGO and SHENZHEN, China, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Shenzhen Salubris Pharmaceuticals Co. Ltd. (Salubris, SZSE: 002294) and Viracta Therapeutics, Inc. announced the initial closing of a financing, with Salubris committing $10 million as the lead investor. New investor Virtus Inspire Ventures, as well as Viracta’s existing investors, NantKwest, Inc., Latterell Venture Partners and Forward Ventures, all participated in the financing. In addition to the financing, Salubris and Viracta
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Salubris Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Salubris (Suzhou) Pharmaceuticals Co., Ltd. is a wholly-owned subsidiary as well as an important business unit for biologics development of Shenzhen Salubris Pharmaceuticals Co., Ltd. The company consists of business operation units that focus on process development and optimization, prokaryotic production by E. coli fermentation and eukaryotic pro... Read More
